Renewing Stelara (Ustekinumab) Approval with Blue Cross Blue Shield in Washington: Complete 2025 Guide
Answer Box: Renewing Stelara Coverage in Washington
To renew Stelara (ustekinumab) with Blue Cross Blue Shield in Washington: Submit updated clinical documentation 30-60 days before your current authorization expires. Include disease activity scores, treatment response data, recent labs (TB screening, CBC, liver function), and specialist notes. Most Washington BCBS plans (Premera, Regence) require annual reauthorization with evidence of ongoing medical necessity. Start by calling the number on your member ID card to confirm renewal requirements and deadlines for your specific plan.
Table of Contents
- Renewal Triggers: When to Start Early
- Evidence Update Requirements
- Your Renewal Documentation Packet
- Timeline and Submission Process
- If Your Coverage Lapses
- Annual Formulary Changes to Watch
- Personal Progress Tracker
- Appeals Process for Denials
- FAQ
Renewal Triggers: When to Start Early
Most Blue Cross Blue Shield plans in Washington require annual reauthorization for Stelara, though some may require reviews every 6 months. Here's when to start preparing:
Start 60-90 Days Before Expiration If:
- You're switching from Stelara to a required biosimilar (Premera plans effective 2025)
- Your disease activity has changed significantly
- You've had any treatment interruptions or dose changes
- Your plan has announced formulary changes
Start 30-45 Days Before for Standard Renewals
- Stable disease with good response
- No major clinical changes
- Same dosing regimen
Note: Premera Blue Cross (Washington's largest BCBS plan) is transitioning Stelara to non-formulary status in 2025, requiring patients to switch to preferred biosimilars like Yesintek. Check your specific plan's 2025 formulary updates.
Evidence Update Requirements
Your renewal application must demonstrate ongoing medical necessity and treatment response. Here's what Washington BCBS plans typically require:
Disease-Specific Response Monitoring
| Condition | Key Measures | Documentation Needed |
|---|---|---|
| Plaque Psoriasis | PASI scores, body surface area affected | Dermatologist notes with numeric scores |
| Psoriatic Arthritis | Joint counts, DAS28 scores, functional assessments | Rheumatologist evaluation with activity measures |
| Crohn's Disease | CDAI scores, fecal calprotectin, endoscopy results | Gastroenterologist notes, lab values |
| Ulcerative Colitis | Mayo scores, colonoscopy findings, symptom logs | GI specialist documentation, imaging reports |
Required Safety Monitoring Labs
Based on FDA prescribing information, include recent results for:
- TB screening: Chest X-ray, QuantiFERON or TST (annually)
- Complete blood count with differential
- Liver function tests (ALT, AST, bilirubin)
- Inflammatory markers (CRP, ESR)
- Hepatitis B/C screening (if indicated)
Tip: Schedule these labs 2-3 months before your renewal deadline to allow time for any abnormal results to be addressed.
Your Renewal Documentation Packet
Core Documents (Always Required)
- Current prior authorization form for your specific BCBS plan
- Specialist's letter of medical necessity (see template below)
- Recent clinical notes (within 3-6 months)
- Laboratory results and monitoring data
- Treatment response documentation
Medical Necessity Letter Template
Your prescribing physician should include:
Patient Information & Diagnosis
- Full name, DOB, member ID
- Primary diagnosis with ICD-10 codes
- Date of initial diagnosis
Treatment History
- Prior therapies tried and failed (with dates, doses, duration)
- Reasons for discontinuation (lack of efficacy, adverse events)
- Documentation of contraindications to preferred alternatives
Current Clinical Status
- Disease activity scores and objective measures
- Functional impact and quality of life
- Response to current Stelara therapy
Ongoing Medical Necessity
- Why Stelara remains the most appropriate treatment
- Plans for continued monitoring
- Expected treatment duration
Timeline and Submission Process
Washington BCBS Plan-Specific Submission
| Plan | Submission Method | Processing Time | Contact |
|---|---|---|---|
| Premera Blue Cross | Online portal or fax | 15-30 business days | Member services on ID card |
| Regence BlueShield | Provider portal or mail | 14-21 business days | 1-888-344-6347 |
Standard Timeline
- Day -60: Begin gathering documentation
- Day -45: Schedule required labs and specialist appointment
- Day -30: Submit complete renewal packet
- Day -15: Follow up if no decision received
- Day 0: Current authorization expires
Important: Submit your renewal before your current authorization expires. Most plans won't provide retroactive coverage for gaps.
If Your Coverage Lapses
Immediate Steps
- Contact your plan immediately to request expedited review
- Ask about emergency supplies (some plans cover 30-day emergency fills)
- Explore manufacturer assistance through Janssen CarePath
Bridge Therapy Options
While not specific to Washington BCBS plans, some insurers offer:
- Temporary authorizations during appeals
- Emergency prescription fills (verify with your plan)
- Expedited review process for urgent cases
Counterforce Health helps patients navigate these coverage gaps by identifying the specific denial reason and crafting targeted appeals that address payer policies directly, often turning denials into approvals within days rather than weeks.
Annual Formulary Changes to Watch
2025 Key Changes for Washington BCBS Plans
Premera Blue Cross
- Stelara moves to non-formulary status in Metallic plans
- Required transition to preferred biosimilars (Yesintek, others)
- Existing authorizations may be grandfathered temporarily
Regence BlueShield
- Enhanced step therapy requirements for biologics
- Tier changes affecting copayments
- New quantity limits on specialty medications
What to Verify Annually
- Your plan's current formulary status for Stelara
- Any new step therapy requirements
- Changes in copayment structure
- Prior authorization form updates
- Preferred pharmacy networks for specialty drugs
Personal Progress Tracker
Use this template to track your renewal process:
Renewal Checklist
- Authorization expiration date: ___________
- Renewal start date (60 days prior): ___________
- Labs scheduled: ___________
- Specialist appointment: ___________
- Documentation submitted: ___________
- Follow-up call made: ___________
- Decision received: ___________
Contact Log
| Date | Contact Method | Person Spoken To | Outcome | Next Steps |
|---|---|---|---|---|
Appeals Process for Denials
If your Stelara renewal is denied, Washington state provides strong appeal rights:
Internal Appeals (Required First Step)
- Timeline: 30 days for pre-service denials, 60 days for post-service
- Expedited option: 72 hours for urgent cases
- How to file: Written request to your BCBS plan
External Review (Independent Review Organization)
Washington's Office of the Insurance Commissioner oversees external reviews:
- When to use: After internal appeals are exhausted
- Timeline: 60 days to request after final internal denial
- Process: Independent medical experts review your case
- Cost: Free to you; insurer pays review fees
- Decision: Binding on the insurance company
From our advocates: We've seen many Washington patients successfully overturn Stelara denials by providing comprehensive documentation of failed prior therapies and current disease activity. The key is demonstrating that biosimilar alternatives aren't appropriate for your specific clinical situation.
Getting Help
- Washington OIC Consumer Advocacy: 1-800-562-6900
- Free appeal assistance: Available through state resources
- Legal aid: For complex cases involving discrimination or bad faith
FAQ
How long does BCBS prior authorization take in Washington? Most Washington BCBS plans process renewals within 15-30 business days. Expedited reviews for urgent cases are completed within 72 hours.
What if Stelara becomes non-formulary on my plan? You can request a formulary exception with clinical justification for why biosimilar alternatives aren't appropriate. Document any previous failures or contraindications to preferred drugs.
Can I request an expedited renewal? Yes, if delaying treatment would seriously jeopardize your health. Your physician must provide clinical documentation supporting the urgent need.
Do I need to restart step therapy for renewals? Generally no, if you're already established on Stelara. However, plans may require documentation that you've tried and failed preferred alternatives within a specific timeframe.
What happens if I move between Washington BCBS plans? Each plan has its own formulary and criteria. You may need to restart the prior authorization process with your new plan, even if you were previously approved.
How do I find my plan's specific renewal requirements? Check your member portal, call the customer service number on your ID card, or visit your plan's drug formulary page online. Requirements can vary significantly between Premera, Regence, and other BCBS affiliates.
About Counterforce Health: Counterforce Health specializes in turning insurance denials into approvals by analyzing denial letters, payer policies, and clinical documentation to create targeted, evidence-based appeals. Our platform helps patients and clinicians navigate complex prior authorization requirements and appeal processes for specialty medications like Stelara.
Sources & Further Reading
- FDA Stelara Prescribing Information
- Premera Blue Cross Drug Formulary
- Washington State Insurance Appeals Process
- Janssen CarePath Patient Support
- Washington Office of Insurance Commissioner
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage policies change frequently. Always verify current requirements with your specific plan and consult with your healthcare provider about treatment decisions. For personalized assistance with appeals, contact the Washington Office of the Insurance Commissioner at 1-800-562-6900.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.